Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LIM zinc finger domain containing 4 (LIMS4) is a small protein (117 amino acids, 13.3 kDa) characterized by the presence of a LIM domain, a double zinc finger structural motif that mediates protein-protein interactions. Proteins with LIM domains often function as adaptor or scaffold proteins, localizing to cytoskeletal structures and involved in the organization of the actin cytoskeleton, cell adhesion, and potentially signal transduction. Although the specific molecular function and signaling partners of LIMS4 remain poorly characterized, its family is broadly implicated in the regulation of cytoskeleton dynamics and cell architecture. Pathogenic variants in LIMS4 have been associated with rare inherited diseases such as Joubert syndrome 4 and Armfield syndrome. There are currently no therapeutic drugs, established mechanisms of action, or biomarker applications specifically related to LIMS4.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LIM zinc finger domain containing 4 (LIMS4).